• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

地尔硫䓬和尼群地平可抑制静息心室心肌的缺氧性挛缩。

Diltiazem and nitrendipine suppress hypoxic contracture in quiescent ventricular myocardium.

作者信息

Henry P D, Wahl A M

出版信息

Eur Heart J. 1983 Nov;4(11):819-22. doi: 10.1093/oxfordjournals.eurheartj.a061404.

DOI:10.1093/oxfordjournals.eurheartj.a061404
PMID:6653595
Abstract

Calcium blocking agents may protect the ischaemic heart by reducing ventricular afterload and cardiac contractility, or by augmenting myocardial perfusion. To determine whether protection is mediated in part by mechanisms unrelated to myocardial work and perfusion, we examined effects of diltiazem and nitrendipine on unperfused myocardium subjected to hypoxia. Rabbit right ventricular papillary muscles were mounted in a myograph containing Krebs buffer equilibrated at 37 degrees C with 95% O2-5% CO2. During brief electrical pacing at a frequency of 12 min-1, a preload of 1363 +/- 60 mg produced a maximal isometric force development of 4892 +/- 273 mg (SE; n = 113). After 60 min without pacing, the quiescent muscles were pre-equilibrated randomly for 20 min without drug for control (C = 38), or with 10(-6) diltiazem (n = 38) or 10(-6) mol l-1 nitrendipine (n = 38). Changes in resting force during equilibration did not exceed +/- 12 mg. Subsequent sudden de-oxygenation with 95% N2-5% CO2 evoked in controls an increase in force beginning after 16 +/- 1 min. The onset of hypoxic contracture was significantly (P less than 0.1) delayed in treated muscles and started after 31 +/- 3 min with diltiazem and after 23 +/- 2 min with nifedipine. Peak contracture was significantly (P less than 0.1) inhibited by diltiazem and nitrendipine compared to controls, respectively values averaging 264 +/- 22 mg, 480 +/- 44 mg and 895 +/- 70 mg. Thus, calcium blockers delayed and suppressed hypoxic contracture in quiescent myocardium, demonstrating that the drugs acted directly on cardiac muscle in the absence of rhythmic electrical and mechanical activity.

摘要

钙阻滞剂可通过降低心室后负荷和心肌收缩力,或通过增加心肌灌注来保护缺血心脏。为了确定这种保护作用是否部分由与心肌做功和灌注无关的机制介导,我们研究了地尔硫卓和尼群地平对缺氧未灌注心肌的影响。将兔右心室乳头肌安装在含有用95% O₂ - 5% CO₂在37℃平衡的 Krebs 缓冲液的肌动描记器中。在以12次/分钟的频率进行短暂电刺激期间,1363±60mg的前负荷产生了4892±273mg(标准误;n = 113)的最大等长力。在无刺激60分钟后,将静止的肌肉随机预平衡20分钟,一组不加药物作为对照(C = 38),一组加入10⁻⁶地尔硫卓(n = 38)或10⁻⁶mol/L尼群地平(n = 38)。平衡期间静息力的变化不超过±12mg。随后用95% N₂ - 5% CO₂突然脱氧,对照组在16±1分钟后开始出现力增加。在用药的肌肉中,缺氧挛缩的开始明显延迟(P < 0.1),用地尔硫卓的肌肉在31±3分钟后开始,用硝苯地平的肌肉在23±2分钟后开始。与对照组相比,地尔硫卓和尼群地平分别显著抑制了挛缩峰值(P < 0.1),平均峰值分别为264±22mg、480±44mg和895±70mg。因此,钙阻滞剂延迟并抑制了静止心肌中的缺氧挛缩,表明这些药物在没有节律性电活动和机械活动的情况下直接作用于心肌。

相似文献

1
Diltiazem and nitrendipine suppress hypoxic contracture in quiescent ventricular myocardium.地尔硫䓬和尼群地平可抑制静息心室心肌的缺氧性挛缩。
Eur Heart J. 1983 Nov;4(11):819-22. doi: 10.1093/oxfordjournals.eurheartj.a061404.
2
Different negative inotropic activity of Ca2(+)-antagonists in human myocardial tissue.钙通道阻滞剂在人心肌组织中的不同负性肌力活性。
Klin Wochenschr. 1990 Aug 17;68(16):797-805. doi: 10.1007/BF01796269.
3
Diltiazem-like effect of thioridazine on the dihydropyridine binding site of the calcium channel of rat myocardial membranes.硫利达嗪对大鼠心肌膜钙通道二氢吡啶结合位点的类似地尔硫䓬的作用。
Biochem Biophys Res Commun. 1984 Jun 15;121(2):657-63. doi: 10.1016/0006-291x(84)90232-8.
4
Tissue response selectivity of calcium antagonists is not due to heterogeneity of [3H]-nitrendipine binding sites.钙拮抗剂的组织反应选择性并非源于[3H]-尼群地平结合位点的异质性。
Br J Pharmacol. 1984 Jun;82(2):309-20. doi: 10.1111/j.1476-5381.1984.tb10765.x.
5
Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes.钙通道拮抗剂维拉帕米和地尔硫䓬对大鼠脑突触体中[³H]尼群地平结合的温度依赖性调节
J Pharmacol Exp Ther. 1984 May;229(2):333-9.
6
Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart.慢通道抑制剂对梗死心肌的保护作用。维拉帕米、硝苯地平及地尔硫䓬对冠状动脉结扎的离体工作大鼠心脏的比较效应。
Circ Res. 1983 Feb;52(2 Pt 2):I129-38.
7
Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.地尔硫䓬、硝苯地平及维拉帕米的变时性、变力性和血管舒张作用。生理反应与膜受体活性的比较研究。
Circ Res. 1983 Feb;52(2 Pt 2):I29-39.
8
Allosteric modulation by diltiazem and verapamil of [3H]nitrendipine binding to calcium channel sites in rat brain.地尔硫䓬和维拉帕米对[³H]尼群地平与大鼠脑钙通道位点结合的变构调节作用。
Proc West Pharmacol Soc. 1983;26:219-24.
9
Comparative effects of verapamil, nifedipine, and diltiazem on contractile function in the isolated immature and adult rabbit heart.维拉帕米、硝苯地平与地尔硫䓬对离体未成熟及成年兔心脏收缩功能的比较效应
Pediatr Res. 1984 Oct;18(10):948-52. doi: 10.1203/00006450-198410000-00008.
10
Effects of bepridil and diltiazem on [3H]nitrendipine binding to canine cardiac sarcolemma. Potentiation of pharmacological effects of nitrendipine by bepridil.苄普地尔和地尔硫䓬对[³H]尼群地平与犬心肌肌膜结合的影响。苄普地尔对尼群地平药理作用的增强作用。
J Pharmacol Exp Ther. 1986 Apr;237(1):40-8.

引用本文的文献

1
Effects of felodipine on the ischemic heart: insight into the mechanism of cytoprotection.非洛地平对缺血性心脏的影响:对细胞保护机制的深入了解。
Cardiovasc Drugs Ther. 1996 Sep;10(4):425-37. doi: 10.1007/BF00051107.
2
Effect of lacidipine on ischaemic and reperfused isolated rabbit hearts.拉西地平对离体兔缺血再灌注心脏的影响。
Mol Cell Biochem. 1993 Aug 11;125(1):73-86. doi: 10.1007/BF00926837.
3
Cardioprotection by the calcium antagonist PN 200-110 in the absence and presence of cardiodepression.在存在和不存在心脏抑制的情况下,钙拮抗剂PN 200 - 110的心脏保护作用。
Br J Pharmacol. 1985 Sep;86(1):181-9. doi: 10.1111/j.1476-5381.1985.tb09448.x.
4
Effect of D-600 on ischemic and reperfused rabbit myocardium: relation with timing and modality of administration.D-600对兔缺血再灌注心肌的影响:与给药时间和方式的关系。
Basic Res Cardiol. 1989 Nov-Dec;84(6):606-22. doi: 10.1007/BF01906946.
5
Isradipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease.伊拉地平。对其药效学和药代动力学特性以及在心血管疾病治疗中的应用的综述。
Drugs. 1990 Jul;40(1):31-74. doi: 10.2165/00003495-199040010-00004.